SCHEMBL5481803

SCHEMBL5481803

COc1cc(C)cc(Cl)c1C(C(=O)O)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CNR2 P34972 1/20 0.42
TTR P02766 1/20 0.40
ACHE P22303 1/20 0.39
TAS1R3 Q7RTX0 1/20 0.39
TAS1R1 Q7RTX1 1/20 0.39
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA4 P22748 2/20 0.38
CA6 P23280 2/20 0.38
CA7 P43166 2/20 0.38
CA9 Q16790 2/20 0.38
CA14 Q9ULX7 2/20 0.38
CA3 P07451 1/20 0.38
PKM P14618 1/20 0.38
CA5A P35218 1/20 0.38
CA5B Q9Y2D0 1/20 0.38
AKR1C3 P42330 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1814307 0.85 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2CNR2ACHETAS1R3
SCHEMBL6306274 0.83 TPMT (0.39) ALDH1A1AKR1C2LMNAKDM4EMAPT
SCHEMBL6838455 0.78 ALDH1A1 (0.42) ALDH1A1CA12CA1CA2CA9
SCHEMBL16554038 0.76 ACACB (0.38) ALDH1A1CNR2TTRCA12CA1
SCHEMBL12269966 0.76 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2CNR2ACHETAS1R3
SCHEMBL5570549 0.72 KDM4E (0.41) ALDH1A1CNR2LMNAERN1STING1
SCHEMBL1424023 0.71 PTGS1 (0.46) ALDH1A1SMN1; SMN2AKR1C2STING1KDM4E
SCHEMBL7486568 0.71 MAPK1 (0.43) ALDH1A1SMN1; SMN2TAS1R3TAS1R1CA12
SCHEMBL16554097 0.70 ERN1 (0.38) ALDH1A1TAS1R3TAS1R1ERN1MAPT
SCHEMBL31458693 0.70 MYC (0.40) ALDH1A1SMN1; SMN2KDM4ETPMTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070298968-A1 2,4,6-Phenyl-Substituted Cyclic Ketoenols BAYER CROPSCIENCE AG (DE) 2007-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070298968-A1 2,4,6-Phenyl-Substituted Cyclic Ketoenols CYP4X1, KCNE1, KDM4E ALDH1A1 2441/4885SMN1; SMN2 4169/4885CNR2 771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.